TrialJournal of bone and mineral metabolism2019

Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials.

Katsuhiko Nakatsukasa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.